Peter Chang

8.3k citations
156 papers · 5.9k · 1 hit paper · h-index 36

Impact in

Papers in

Peter Chang

146 papers receiving 5.6k citations

Peter Chang's Hit Papers

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis 2010 · 798 citations
7980+5+10Years since publication250500750

Peers

Peter Chang
Comparison fields: 5 of 138
  • Pathology and Forensic Medicine 1.9k
  • Pulmonary and Respiratory Medicine 1.6k
  • Rheumatology 629
  • Neurology 523
  • Oncology 654
Replace Kazumoto Iijima with:
Kazumoto Iijima Japan
Edward Fox United States
Sonye Karen Danoff United States
Marc E. Horowitz United States
Oliver Hartmann Germany
Jean‐Pierre Grünfeld France
Franz Quehenberger Austria
Riccardo Saccardi Italy
Chia‐Jen Liu Taiwan
Karin Ekstrom Ekstroem Smedby Sweden
Peter Chang relative to Kazumoto Iijima Japan Kazumoto Iijima's profile →
Citations per field
00.5×1.5×2.0×
Kazumoto Iijima · 1×
Citations per year

Countries citing papers authored by Peter Chang

Since Specialization
Citations

This map shows the geographic impact of Peter Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Chang more than expected).

Fields of papers citing papers by Peter Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Chang. The network helps show where Peter Chang may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Chang Line = papers co-authored together Peter Chang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 156 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Hit paper breakdown →
2010798
2 2002509
3 2008388
4 2005307
5 2015290
6 2014270
7 2017197
8 2005158
9 2011156
10 2010145
11 1998113
12 2019100
13 200592
14 201790
15 198388
16 201486
17 200784
18 201879
19 200576
20 201367

About Peter Chang

Peter Chang is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Surgery, Urology and Oncology, having authored 156 papers that have together received 5.9k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (30 papers), Renal cell carcinoma treatment (24 papers), Bladder and Urothelial Cancer Treatments (15 papers), Multiple Sclerosis Research Studies (13 papers), Prostate Cancer Treatment and Research (7 papers), Renal and related cancers (6 papers), Systemic Lupus Erythematosus Research (5 papers) and Lysosomal Storage Disorders Research (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.9k citations), Pulmonary and Respiratory Medicine (1.6k citations), Rheumatology (629 citations), Neurology (523 citations) and Oncology (654 citations). Peter Chang has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Patricia Katherine Coyle, Andrew Aurel Wagner, Kottil W Rammohan, G. Francis, Steven J. Greenberg, Per Soelberg Sørensen, Anthony Hamlett, Gıancarlo Comı, Gavin Giovannoni and Patrick Vermersch. Their work appears in journals such as The Journal of Urology, Urologic Oncology Seminars and Original Investigations, Urology, International Journal of Radiation Oncology*Biology*Physics and Prostate Cancer and Prostatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact